Evidence map›Paper›PMID 42388500›Full record

SynthesisFrontiers in medicine2026

Lingyun Zhang, Yuexia Zhang, Lei Qiao, Ruihan Wu, Feng He, Yuxin Guan, Lei Li

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lingyun ZhangDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Yuexia ZhangHealth Management Center, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Lei QiaoDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Ruihan WuDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Feng HeDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Yuxin GuanDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
Lei LiDepartment of Gastroenterology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Metabolic-associated fatty liver disease (MAFLD) is a global health concern. Observational evidence has suggested a possible relationship between Methods: We searched the international databases PubMed, Embase and Web of Science and the Chinese databases China National Knowledge Infrastructure, Chinese Scientific Journal Database (VIP) and Wanfang between January 2015 and December 2024. Observational studies reporting Results: Seven studies, comprising 11,168 participants (4,980 Conclusion: Current evidence does not demonstrate a statistically significant overall association between

Indexed as

Helicobacter pylorimeta-analysismetabolic-associated fatty liver diseaseseverity of illness indexstudy

Identifiers

PMID42388500
PMCPMC13318565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.